One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2019-126064
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 18 |
Affiliation: Cleveland Clinic, Sarah Cannon, Stanford University, Moffitt Cancer Center, Swedish Medical Center, Dana-Farber Cancer Institute, University of California, Los Angeles, Texas Oncology, The Ohio State University, Colorado Blood Cancer Institute, The University of Texas MD Anderson Cancer Center, Academic Medical Center, University of Amsterdam, Hackensack University Medical Center, University of Rochester Medical CenterKTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results of the Phase 2 ZUMA-2 Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
